Alessa Therapeutics develops localized treatments for solid organ disease.
Alessa Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Alessa Therapeutics's investors include Mission BioCapital, Johnson & Johnson.
Alessa Therapeutics is headquartered in San Francisco, United States.
Alessa Therapeutics develops localized treatments for solid organ disease.
Alessa Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alessa Therapeutics — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/alessa-therapeutics. Accessed October 30, 2026.
VCBacked. (2024). Alessa Therapeutics — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/alessa-therapeutics
{{cite web |title=Alessa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alessa-therapeutics |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated